Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Cohen

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Oncotarget|October 19, 2018
RND1 regulates migration of human glioblastoma stem-like cells according to their anatomical localization and defines a prognostic signature in glioblastomaSabrina Boyrie, Caroline Delmas, Anthony Lemarié, et al.
Plos One|April 14, 2015
Metformin inhibits growth of human glioblastoma cells and enhances therapeutic responseJulie Sesen, Perrine Dahan, Sarah J Scotland, et al.
Oncotarget|September 17, 2017
A phase 1 dose-escalation study of the oral histone deacetylase inhibitor abexinostat in combination with standard hypofractionated radiotherapy in advanced solid tumorsEric Deutsch, Elizabeth Cohen-Jonathan Moyal, Vanesa Gregorc, et al.
Science Advances|November 3, 2023
The STEMRI trial: Magnetic resonance spectroscopy imaging can define tumor areas enriched in glioblastoma stem-like cellsAnthony Lemarié, Vincent Lubrano, Caroline Delmas, et al.
NAR Cancer|July 28, 2021
Translation reprogramming by eIF3 linked to glioblastoma resistanceJuliette Bertorello, Julie Sesen, Julia Gilhodes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 6, 2023
Is pre-radiotherapy metabolic heterogeneity of glioblastoma predictive of progression-free survival?Fatima Tensaouti, Franck Desmoulin, Julia Gilhodes, et al.
Magnetic Resonance in Medicine|November 26, 2021
Quality control of 3D MRSI data in glioblastoma: Can we do without the experts?Fatima Tensaouti, Franck Desmoulin, Julia Gilhodes, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2024
REVOLUMAB: A phase II trial of nivolumab in recurrent IDH mutant high-grade gliomasAlberto Picca, Mehdi Touat, Lisa Belin, et al.
The Lancet. Oncology|August 1, 2014
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastomaMichael Weller, Martin van den Bent, Kirsten Hopkins, et al.
The Lancet. Oncology|September 7, 2016
EANO guidelines for the diagnosis and treatment of meningiomasRoland Goldbrunner, Giuseppe Minniti, Matthias Preusser, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Oncotarget|October 19, 2018
RND1 regulates migration of human glioblastoma stem-like cells according to their anatomical localization and defines a prognostic signature in glioblastomaSabrina Boyrie, Caroline Delmas, Anthony Lemarié, et al.
Plos One|April 14, 2015
Metformin inhibits growth of human glioblastoma cells and enhances therapeutic responseJulie Sesen, Perrine Dahan, Sarah J Scotland, et al.
Oncotarget|September 17, 2017
A phase 1 dose-escalation study of the oral histone deacetylase inhibitor abexinostat in combination with standard hypofractionated radiotherapy in advanced solid tumorsEric Deutsch, Elizabeth Cohen-Jonathan Moyal, Vanesa Gregorc, et al.
Science Advances|November 3, 2023
The STEMRI trial: Magnetic resonance spectroscopy imaging can define tumor areas enriched in glioblastoma stem-like cellsAnthony Lemarié, Vincent Lubrano, Caroline Delmas, et al.
NAR Cancer|July 28, 2021
Translation reprogramming by eIF3 linked to glioblastoma resistanceJuliette Bertorello, Julie Sesen, Julia Gilhodes, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 6, 2023
Is pre-radiotherapy metabolic heterogeneity of glioblastoma predictive of progression-free survival?Fatima Tensaouti, Franck Desmoulin, Julia Gilhodes, et al.
Magnetic Resonance in Medicine|November 26, 2021
Quality control of 3D MRSI data in glioblastoma: Can we do without the experts?Fatima Tensaouti, Franck Desmoulin, Julia Gilhodes, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2024
REVOLUMAB: A phase II trial of nivolumab in recurrent IDH mutant high-grade gliomasAlberto Picca, Mehdi Touat, Lisa Belin, et al.
The Lancet. Oncology|August 1, 2014
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastomaMichael Weller, Martin van den Bent, Kirsten Hopkins, et al.
The Lancet. Oncology|September 7, 2016
EANO guidelines for the diagnosis and treatment of meningiomasRoland Goldbrunner, Giuseppe Minniti, Matthias Preusser, et al.
Pageof 11